Palomino Laboratories Inc. (PALX) stock
PALXOTCSemiconductors & Related DevicesFiscal year ends December 31
$14.00−0.32 (-2.23%)
Close on Oct 15, 2026Market cap $305.46MP/E –Yield –
Palomino Laboratories operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Palomino Laboratories's operating income for the twelve months ending Jun 30, 2026 was -$4.96M. For fiscal 2025 it was -$2.70M.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$2.70M | – |
| FY2024 | Dec 31, 2024 | -$6.12K | – |
| FY2023 | Dec 31, 2023 | -$83.94K | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$1.37M | – |
| Q1 FY2026 | Mar 31, 2026 | -$1.24M | – |
| Q4 FY2025 | Dec 31, 2025 | -$742.64K | – |
| Q3 FY2025 | Sep 30, 2025 | -$1.60M | – |
| Q2 FY2025 | Jun 30, 2025 | -$337.45K | – |
| Q1 FY2025 | Mar 31, 2025 | -$17.83K | – |
| Q4 FY2024 | Dec 31, 2024 | -$4.01K | – |
| Q3 FY2024 | Sep 30, 2024 | -$1.23K | – |
| Q2 FY2024 | Jun 30, 2024 | -$31.79K | – |
| Q1 FY2024 | Mar 31, 2024 | -$51.30K | – |
| Q4 FY2023 | Dec 31, 2023 | -$32.57K | – |
| Q3 FY2023 | Sep 30, 2023 | -$42.86K | – |
| Q3 FY2022 | Sep 30, 2022 | -$4.25K | – |
See a number that looks wrong?